Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bruna

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
European Journal of Neurology|November 9, 2017
Seizure-susceptible brain regions in glioblastoma: identification of patients at riskN Cayuela, M Simó, C Majós, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coinP Alberti, E Rossi, D R Cornblath, et al.
Journal of Neuro-Oncology|June 12, 2020
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric studyR Velasco, S Mercadal, N Vidal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
European Journal of Neurology|November 9, 2017
Seizure-susceptible brain regions in glioblastoma: identification of patients at riskN Cayuela, M Simó, C Majós, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coinP Alberti, E Rossi, D R Cornblath, et al.
Journal of Neuro-Oncology|June 12, 2020
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric studyR Velasco, S Mercadal, N Vidal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Pageof 14